Anna Nowak, MD, PhD, Talks Immunotherapy + Chemotherapy (and much more) for Mesothelioma

Press/Media: Press / Media


Interview with Anna Nowak, MD, PhD, speaking about immunotherapy and combination of immunotherapy and chemotherapy for mesothelioma patients. She also discusses COVID-19's effects on mesothelioma in treatment in Australia. Interviewed by Mary Hesdorffer, nurse practitioner and executive director of the Mesothelioma Applied Research Foundation.

Dr. Nowak is a medical oncologist at Sir Charles Gairdner Hospital (SCGH) and professor within the School of Medicine at The University of Western Australia.

Period1 Jun 2020